Most Clicked StoriesMore >


Celgene invests $50M in partnership with 4 cancer centers

BIO SmartBrief | Jun 23, 2016

Celgene has agreed to pay a total of $50 million to access research on new cancer treatments and diagnostics by a consortium of four academic cancer centers in a 10-year research collaboration, with each institution to receive $12.5 million from the firm. The consortium was established through the Cancer Trust and includes cancer centers at the Columbia University Medical Center, University of Pennsylvania, Icahn School of Medicine at Mount Sinai and Johns Hopkins. Genetic Engineering & Biotechnology News (06/22)


Teva sells generic drugs to Impax for $586M

BIO SmartBrief | Jun 22, 2016

Cell Medica partners with Baylor to co-develop immunotherapies

BIO SmartBrief | Jun 20, 2016

Human trials for Zika vaccine from Inovio, GeneOne approved by FDA

BIO SmartBrief | Jun 21, 2016

GVHD drug from Incyte gains FDA breakthrough status

BIO SmartBrief | Jun 24, 2016

BARDA gives Cerus up to $180 million for INTERCEPT system development

BIO SmartBrief | Jun 21, 2016

Human testing of CRISPR gene editing to be reviewed by NIH

BIO SmartBrief | Jun 20, 2016

Novartis to add 5 new biosimilars

BIO SmartBrief | Jun 21, 2016

IPO brings in $70M for Selecta

BIO SmartBrief | Jun 23, 2016

FDA fast-tracks Fate's drug for GvHD treatment

BIO SmartBrief | Jun 21, 2016


Find BIO SmartBrief Issues by Date:



BIO News More >


Registration is open for the 2016 BIO Latin America Conference

BIO SmartBrief | Jun 24, 2016

BIO survey to support PDUFA 6 negotiations

BIO SmartBrief | Jun 24, 2016

Executive liability coverage for life sciences companies

BIO SmartBrief | Jun 23, 2016

RFS policy instability continues to chill investment in advanced biofuels, BIO says

BIO SmartBrief | Jun 22, 2016

Savings on environmental waste disposal services

BIO SmartBrief | Jun 21, 2016




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more